BBIO

BridgeBio Pharma Inc — AI technical analysis, October 2026
NYSE/NASDAQ · Biotechnology
Technical Signal
BUY
Technical score 100/100
Last price: $67.25  ·  52W range $51.85 – $93.42
Short answer

Should you buy BBIO right now? Stockgaide's algorithm rates BBIO as BUY (technical signal), with a technical score of 100/100 at a last price of $67.25. The 50-day average is above the 200-day average, and RSI sits at 37.0. Wall Street's consensus rating is 1.90/5.

Technical signal details

Rule-based read from price and momentum indicators only — the score behind the technical signal above. Technical score: 100/100 (BUY).

Technical indicators

RSI (14)
37.0
SMA 50
76.33
SMA 200
73.58
MACD hist
0.344

Fundamentals & Wall Street

Market Cap
$13.08B
P/E (TTM)
—
Dividend Yield
—
Analyst Consensus
1.90 / 5

Analyst ratings: 26 Buy · 3 Hold · 0 Sell (1 = Strong Buy, 5 = Strong Sell)

BBIO stock: frequently asked questions

Is BBIO a buy right now?

Stockgaide's AI currently rates BBIO as BUY (technical signal), with a technical score of 100 out of 100 at a last price of $67.25. This is educational content, not investment advice.

Is BBIO in an uptrend?

BBIO's 50-day moving average (76.33) is above its 200-day moving average (73.58), which points to a medium-term uptrend.

What is BBIO's RSI today?

BBIO has a 14-day RSI of 37.0, which places it in neutral territory (above 70 is overbought, below 30 is oversold).

What do analysts say about BBIO?

Wall Street analysts covering BBIO have a consensus rating of 1.90 out of 5 (1 = Strong Buy), meaning they lean Buy — 26 Buy · 3 Hold · 0 Sell.

Where is BBIO trading in its 52-week range?

BBIO last traded at $67.25, against a 52-week range of $51.85 to $93.42 — about 37% of the way up that range.

Get the full AI analysis of BBIO

Price targets, fundamentals deep-dive and an AI-written report — free, no signup.

Analyze BBIO now →
Data updated Oct 2, 2026 · refreshed daily